Back to Search
Start Over
Multiple drugs: Cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy.
- Source :
-
Reactions Weekly . 6/8/2024, Vol. 2011 Issue 1, p269-269. 1p. - Publication Year :
- 2024
-
Abstract
- A 74-year-old woman with central nervous system-relapsed mantle cell lymphoma experienced grade 1 cytokine release syndrome and grade 2 immune effector cell-associated neurotoxicity syndrome during treatment with brexucabtagene-autoleucel. She also showed a lack of efficacy with various other treatments, including rituximab, ibrutinib, methotrexate, cytarabine, dexamethasone, and tocilizumab. Despite these challenges, the woman achieved complete remission of mantle cell lymphoma after treatment with brexucabtagene-autoleucel. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 01149954
- Volume :
- 2011
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Reactions Weekly
- Publication Type :
- Periodical
- Accession number :
- 177796701
- Full Text :
- https://doi.org/10.1007/s40278-024-60504-z